Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.9405
-0.1295 (-12.10%)
At close: May 26, 2026, 4:00 PM EDT
0.9546
+0.0141 (1.50%)
After-hours: May 26, 2026, 7:19 PM EDT

RANI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
941644686149322
Market Cap Growth
260.35%259.69%-47.20%-42.08%-53.69%-
Enterprise Value
56.9125.6732.7574.96117.12278.99
Last Close Price
0.941.351.373.325.9016.35
PS Ratio
30.41100.5244.39--118.62
PB Ratio
3.764.9722.916.724.056.80
P/TBV Ratio
3.392.7119.586.583.816.74
EV/Sales Ratio
17.9576.9631.86--102.69
Debt / Equity Ratio
0.070.073.790.960.390
Net Debt / Equity Ratio
-1.39-1.371.04-1.43-1.85-2.48
Net Debt / EBITDA Ratio
1.141.21-0.040.281.092.30
Net Debt / FCF Ratio
-2.41-0.060.351.423.59
Asset Turnover
0.060.030.02000.03
Quick Ratio
3.284.081.416.0820.4544.49
Current Ratio
3.404.211.506.3620.9645.30
Return on Equity (ROE)
-94.03%-181.98%-391.10%-136.52%-64.78%-1290.42%
Return on Assets (ROA)
-62.69%-80.44%-112.77%-79.66%-54.58%-50.64%
Return on Invested Capital (ROIC)
-914.84%-749.49%-848.54%-1037.74%-1286.92%-1116.12%
Return on Capital Employed (ROCE)
-82.49%-122.21%-159.93%-86.33%-56.46%-52.74%
Buyback Yield / Dilution
-238.89%-132.26%-11.65%-7.09%-21.93%58.34%
Total Shareholder Return
-238.89%-132.26%-11.65%-7.09%-21.93%58.34%
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q